N-(4-((3-BUTYL-2,3,6,9-TETRAHYDRO-2,6-DIOXO-1-(2-PROPEN-1-YL)-1H-PURIN-8-YL)METHYL)PHENYL)ACETAMIDE
UNII 5JVX56QVT5
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-((3-butyl-2,3,6,9-tetrahydro-2,6-dioxo-1-(2-propen-1-yl)-1h-purin-8-yl)methyl)phenyl)acetamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5JVX56QVT5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 628279-02-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H25N5O3 XFOWZKUTPKXWIE-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-((3-butyl-2,3,6,9-tetrahydro-2,6-dioxo-1-(2-propen-1-yl)-1h-purin-8-yl)methyl)phenyl)acetamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.